1. 2022
  2. Altered Gut Structure and Anti-Bacterial Defense in Adult Mice Treated with Antibiotics during Early Life

    Garcia, T. N. M., van Roest, M., Vermeulen, J. L. M., Meisner, S., Koster, J., Wildenberg, M. E., van Elburg, R. M., Muncan, V. & Renes, I. B., 1 Feb 2022, In: Antibiotics (Basel, Switzerland). 11, 2, 267.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Autoantibody formation against a canalicular epitope found in a patient with acute intrahepatic cholestasis with PFIC-like presentation

    Schumacher, J., Herta, T., Stindt, J., Keitel, V. & Berg, T., 1 Feb 2022, In: JHEP Reports. 4, 2, 100418.

    Research output: Contribution to journalComment/Letter to the editorAcademic

  4. Evaluation of Inhibitory Antibodies against the Muscarinic Acetylcholine Receptor Type 3 in Patients with Primary Biliary Cholangitis and Primary Sclerosing Cholangitis

    Wilde, A-C. B., Greverath, L. M., Steinhagen, L. M., de Chamorro, N. W., Leicht, E., Fischer, J., Herta, T., Berg, T., Preuss, B., Klein, R., Tacke, F. & Müller, T., 1 Feb 2022, In: Journal of clinical medicine. 11, 3, 681.

    Research output: Contribution to journalArticleAcademicpeer-review

  5. Incidence, Clinical Characteristics and Outcomes of Early Hyperbilirubinemia in Critically Ill Patients: Insights From the MARS Study

    Juschten, J., Bos, L. D. J., de Grooth, H-J., Beuers, U., Girbes, A. R. J., Juffermans, N. P., Loer, S. A., van der Poll, T., Cremer, O. L., Bonten, M. J. M., MARS consortium, Schultz, M. J. & Tuinman, P. R., 1 Feb 2022, In: Shock (Augusta, Ga.). 57, 2, p. 161-167 7 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  6. Role of the IgG4-related cholangitis autoantigen annexin A11 in cholangiocyte protection

    Herta, T., Kersten, R., Chang, J-C., Hubers, L., Go, S., Tolenaars, D., Paulusma, C. C., Nathanson, M. H., Elferink, R. O., van de Graaf, S. F. J. & Beuers, U., 1 Feb 2022, In: Journal of hepatology. 76, 2, p. 319-331 13 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  7. The Role of the Lymphatic System in the Pathogenesis and Treatment of Inflammatory Bowel Disease

    Nikolakis, D., de Voogd, F. A. E., Pruijt, M. J., Grootjans, J., van de Sande, M. G. & D’haens, G. R., 1 Feb 2022, In: International journal of molecular sciences. 23, 3, 1854.

    Research output: Contribution to journalReview articleAcademicpeer-review

  8. MiR-511 deficiency protects mice from experimental colitis by reducing TLR3 and TLR4 responses via WD repeat and FYVE-domain-containing protein 1

    Rahman, S., Vandewalle, J., van Hamersveld, P. H. P., Verseijden, C., Welting, O., Jongejan, A., Casanova, P., Meijer, S. L., Libert, C., Hakvoort, T. B. M., de Jonge, W. J. & Heinsbroek, S. E. M., 1 Jan 2022, In: Cells. 11, 1, 58.

    Research output: Contribution to journalArticleAcademicpeer-review

  9. Nutritional therapies and their influence on the intestinal microbiome in pediatric inflammatory bowel disease

    Hart, L., Verburgt, C. M., Wine, E., Zachos, M., Poppen, A., Chavannes, M., van Limbergen, J. & Pai, N., 1 Jan 2022, In: Nutrients. 14, 1, 4.

    Research output: Contribution to journalReview articleAcademicpeer-review

  10. Autotaxin, PPARs, and FGF21: An Eye Opener for Progressive Liver Disease?

    Beuers, U. & Oude Elferink, R., Jan 2022, In: Cellular and molecular gastroenterology and hepatology. 14, 5, p. 1168-1169 2 p.

    Research output: Contribution to journalEditorialAcademicpeer-review

  11. SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study

    COVIDSurg Collaborative, Gisbertz, S. S., Borgstein, A. B. J., van Berge Henegouwen, M. I., Bloemers, F. W., Study group members AMC, Bakx, R., Besselink, M. G. H., Lemmers, D. H. L., van Amstel, P. & van Helsdingen, C. P. M., Jan 2022, In: Anaesthesia. 77, 1, p. 28-39 12 p.

    Research output: Contribution to journalArticleAcademicpeer-review

Previous 1...4 5 6 7 8 9 10 11 ...125 Next

ID: 19672